Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bahra

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Injury|April 28, 2020
Clinical course and pancreas parenchyma sparing surgical treatment of severe pancreatic traumaS Chikhladze, D A Ruess, J Schoenberger, et al.
The British Journal of Surgery|October 4, 2011
Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomyA J Eckardt, F Klein, A Adler, et al.
British Journal of Cancer|October 15, 2014
α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 studyM Sinn, C Denkert, J K Striefler, et al.
Transplantation Proceedings|August 15, 2002
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growthG Schumacher, M Oidtmann, S Rosewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2015
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trialM Sinn, H Riess, B V Sinn, et al.
Acta Anaesthesiologica Scandinavica|January 24, 2018
Risk factors for 30-day complications after cancer surgery in geriatric patients: a secondary analysisK Scholtz, C D Spies, R Mörgeli, et al.
The British Journal of Surgery|June 11, 2020
COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in EuropeN F Nevermann, K H Hillebrandt, S Knitter, et al.
British Journal of Cancer|July 12, 2007
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosisW Weichert, M Boehm, V Gekeler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 11, 2017
Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resectionG Duwe, S Knitter, S Pesthy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2016
SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Injury|April 28, 2020
Clinical course and pancreas parenchyma sparing surgical treatment of severe pancreatic traumaS Chikhladze, D A Ruess, J Schoenberger, et al.
The British Journal of Surgery|October 4, 2011
Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomyA J Eckardt, F Klein, A Adler, et al.
British Journal of Cancer|October 15, 2014
α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 studyM Sinn, C Denkert, J K Striefler, et al.
Transplantation Proceedings|August 15, 2002
Sirolimus inhibits growth of human hepatoma cells in contrast to tacrolimus which promotes cell growthG Schumacher, M Oidtmann, S Rosewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|June 8, 2015
Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trialM Sinn, H Riess, B V Sinn, et al.
Acta Anaesthesiologica Scandinavica|January 24, 2018
Risk factors for 30-day complications after cancer surgery in geriatric patients: a secondary analysisK Scholtz, C D Spies, R Mörgeli, et al.
The British Journal of Surgery|June 11, 2020
COVID-19 pandemic: implications on the surgical treatment of gastrointestinal and hepatopancreatobiliary tumours in EuropeN F Nevermann, K H Hillebrandt, S Knitter, et al.
British Journal of Cancer|July 12, 2007
High expression of RelA/p65 is associated with activation of nuclear factor-kappaB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosisW Weichert, M Boehm, V Gekeler, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 11, 2017
Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resectionG Duwe, S Knitter, S Pesthy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 2016
SPARC expression in resected pancreatic cancer patients treated with Gemcitabine: results from the CONKO-001 studyM Sinn, B V Sinn, J K Striefler, et al.
Pageof 5